SGA
VRTX icon

Sector Gamma AS’s Vertex Pharmaceuticals VRTX Stock Holding History

Sector Gamma AS’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-33,474
Closed -$9.43M – 37
2022
Q2 		$9.43M Buy
33,474
+8,716
+35% +$2.33M 2.11% 18
2022
Q1 		$6.46M Sell
24,758
-14,311
-37% -$3.4M 1.4% 26
2021
Q4 		$8.58M Buy
+39,069
New +$7.6M 2.02% 22
2017
Q2 		– Sell
-267,050
Closed -$29.2M – 28
2017
Q1 		$29.2M Sell
267,050
-66,900
-20% -$5.89M 4.64% 11
2016
Q4 		$24.6M Buy
333,950
+65,070
+24% +$5.29M 4.63% 10
2016
Q3 		$22.4M Sell
268,880
-10,203
-4% -$964K 3.92% 10
2016
Q2 		$24M Buy
279,083
+70,840
+34% +$6.12M 4.56% 7
2016
Q1 		$16.6M Buy
208,243
+91,610
+79% +$8.29M 3.41% 14
2015
Q4 		$14.7M Buy
116,633
+9,570
+9% +$1.16M 3.77% 11
2015
Q3 		$11.2M Buy
107,063
+33,600
+46% +$4.32M 3.02% 14
2015
Q2 		$9.07M Sell
73,463
-1,000
-1% -$126K 2.32% 19
2015
Q1 		$8.78M Sell
74,463
-28,000
-27% -$3.35M 2.32% 20
2014
Q4 		$12.2M Buy
102,463
+28,000
+38% +$3.15M 2.71% 16
2014
Q3 		$8.36M Buy
+74,463
New +$7.09M 1.96% 21
2013
Q4 		– Sell
-105,800
Closed -$8.02M – 34
2013
Q3 		$8.02M Buy
105,800
+10,500
+11% +$836K 2.06% 20
2013
Q2 		$7.63M Buy
+95,300
New +$7.02M 2.23% 17

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sector Gamma AS's VRTX Position: Q3 2022 in Review

Sector Gamma AS sold out of Vertex Pharmaceuticals (VRTX) in Q3 2022, closing a stake of 33,474 shares — an estimated $9.43M sold.

Sector Gamma AS first reported a position in VRTX in Q2 2013 and held it in 16 quarters. The position peaked at $29.2M in Q1 2017. 1,124 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.

  • Sector Gamma AS reported no remaining Vertex Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Sector Gamma AS sold 33,474 Vertex Pharmaceuticals shares in Q3 2022, an estimated $9.43M.
  • Sector Gamma AS first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • Sector Gamma AS's Vertex Pharmaceuticals position peaked at $29.2M in Q1 2017.
  • 1,124 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.

Based on Sector Gamma AS's 13F filing for Q3 2022, filed 9 Nov 2022.